SEC 13F Intelligence

Sofinnova Investments, Inc. / LLY

Sofinnova Investments, Inc.’s Eli Lilly & Co Position

Does Sofinnova Investments, Inc. own Eli Lilly & Co (LLY)? Not currently — the last reported position was 61.7K shares worth $66M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$66M
Q4 2025
Shares
61.7K
% of Portfolio
+2.86%
Quarters Held
12
position exited

Position History LLY

Reported value by quarter
Q2 ’20: $24MQ2 ’20Q3 ’20: $21MQ4 ’20: $6MQ4 ’20Q1 ’21: $34MQ3 ’22: $15MQ3 ’22Q1 ’23: $47MQ4 ’23: $38MQ4 ’23Q2 ’24: $38MQ4 ’24: $11MQ4 ’24Q1 ’25: $44MQ2 ’25: $76MQ2 ’25Q4 ’25: $66Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q4 202561.7K$66M+2.86%
Q2 202597.0K$76M+4.63%
Q1 202552.8K$44M+2.85%
Q4 202414.4K$11M+0.81%
Q2 202464.5K$38M+2.10%
Q4 202364.5K$38M+2.10%
Q1 2023137.1K$47M+3.01%
Q3 202245.5K$15M+0.86%
Q1 2021180.5K$34M+2.03%
Q4 202036.9K$6M+0.37%
Q3 2020142.4K$21M+1.56%
Q2 2020148.9K$24M+1.54%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Sofinnova Investments, Inc.’s full portfolio or all institutional holders of LLY.